- Home
- MLCO vs WGS Comparison
MLCO vs WGS Comparison
Compare MLCO & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLCO
- WGS
- Stock Information
- Founded
- MLCO 2004
- WGS 2017
- Country
- MLCO Hong Kong
- WGS United States
- Employees
- MLCO N/A
- WGS N/A
- Industry
- MLCO Hotels/Resorts
- WGS Retail: Computer Software & Peripheral Equipment
- Sector
- MLCO Consumer Discretionary
- WGS Technology
- Exchange
- MLCO Nasdaq
- WGS Nasdaq
- Market Cap
- MLCO 2.4B
- WGS 2.0B
- IPO Year
- MLCO 2006
- WGS N/A
- Fundamental
- Price
- MLCO $5.54
- WGS $69.48
- Analyst Decision
- MLCO Buy
- WGS Strong Buy
- Analyst Count
- MLCO 6
- WGS 5
- Target Price
- MLCO $9.50
- WGS $80.60
- AVG Volume (30 Days)
- MLCO 3.2M
- WGS 787.4K
- Earning Date
- MLCO 02-27-2025
- WGS 02-18-2025
- Dividend Yield
- MLCO N/A
- WGS N/A
- EPS Growth
- MLCO N/A
- WGS N/A
- EPS
- MLCO N/A
- WGS N/A
- Revenue
- MLCO $4,540,808,000.00
- WGS $267,228,000.00
- Revenue This Year
- MLCO $24.87
- WGS $43.70
- Revenue Next Year
- MLCO $5.56
- WGS $17.28
- P/E Ratio
- MLCO N/A
- WGS N/A
- Revenue Growth
- MLCO 50.42
- WGS 29.41
- 52 Week Low
- MLCO $4.78
- WGS $2.85
- 52 Week High
- MLCO $9.39
- WGS $98.87
- Technical
- Relative Strength Index (RSI)
- MLCO 38.61
- WGS 40.28
- Support Level
- MLCO $5.41
- WGS $66.81
- Resistance Level
- MLCO $5.65
- WGS $98.87
- Average True Range (ATR)
- MLCO 0.21
- WGS 7.98
- MACD
- MLCO -0.00
- WGS -2.10
- Stochastic Oscillator
- MLCO 28.00
- WGS 8.33
About MLCO Melco Resorts & Entertainment Limited
Melco Resorts & Entertainment is one of only six licensed casino operators in Macao. It operates Altira, a complex focused on premium customers; City of Dreams, an integrated resort in Cotai serving both mass-market and premium patrons; and Mocha Clubs electronic gaming machines. The company also has a majority interest in Studio City, which opened in 2015. Outside Macao, Melco owns City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus. The business mix in terms of adjusted EBITDA was about 82.5% from Macao with the rest largely from the Philippines as of first-half 2024.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.